Remdesivir has only marginal benefit for moderate COVID-19 patients
The 600-patient analysis found that moderately-ill patients treated with Remdesivir for up to five days had significantly higher…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.